Translating GLP-1 Agonism to Uncover Novel Mechanisms for Neuroprotection in Alzheimer’s and Parkinson’s Disease

• Investigating how GLP-1-based therapies influence the brain beyond feeding behavior regulation – and their relevance for neurodegenerative disease
• Reconsidering the role of glial cells in mediating therapeutic effects of GLP-1R agonism
• Tracing conserved brain responses to GLP-1 modulation across systems

Speakers:

Adriana Ramos

Principal Scinetist

Sanofi